ARMP
Armata Pharmaceuticals Inc
NYSE MKT: ARMP · HEALTHCARE · BIOTECHNOLOGY
$9.87
+3.35% today
Updated 2026-04-30
Market cap
$473.30M
P/E ratio
—
P/S ratio
96.51x
EPS (TTM)
$-4.80
Dividend yield
—
52W range
$1 – $15
Volume
0.1M
Armata Pharmaceuticals Inc (ARMP) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2004 | 2005 | 2006 | 2007 | 2008 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $-15.52M | $-16.39M | $-11.64M | $-13.88M | $-10.30M | $-4.67M | $-4.28M | $-7.45M | $-12.57M | $-9.78M | $-10.59M | $-9.19M | $-9.38M | $-15.58M | $-18.27M | $-23.57M | $-32.48M | $-47.42M | $-37.55M | $-25.76M |
| Capital expenditures | $408000.00 | $669000.00 | $81000.00 | $554000.00 | $738000.00 | $110000.00 | $53000.00 | $102000.00 | $1.20M | $210000.00 | $279000.00 | $58000.00 | $44000.00 | $131000.00 | $824000.00 | $1.30M | $2.21M | $8.14M | $1.88M | $542000.00 |
| Depreciation | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Stock-based comp | — | — | — | $966000.00 | $718000.00 | — | $9000.00 | $1.44M | $1.94M | $483000.00 | $2.00M | $700000.00 | $478000.00 | $4.27M | $3.48M | $2.88M | $3.10M | $938000.00 | $2.89M | $2.61M |
| Free cash flow | $-15.93M | $-17.06M | $-11.72M | $-14.44M | $-11.04M | $-4.78M | $-4.33M | $-7.55M | $-13.77M | $-9.99M | $-10.87M | $-9.25M | $-9.43M | $-15.71M | $-19.09M | $-24.88M | $-34.69M | $-55.57M | $-39.43M | $-26.30M |
| Investing cash flow | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Dividends paid | — | — | — | — | — | — | — | — | — | — | $80000.00 | $0.00 | — | — | — | — | — | — | — | — |
| Share repurchases | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | — | — | — | — | — | — | — | — | — | — | — | — | $4.12M | $639000.00 | $9.32M | — | — | — |